ID1 and neoplasm: We hope that future in vivo application of the peptide aptamer Id1/3-PA7 in tumour-bearing Id1/3 transgenic mice and in Id1+/−Id3−/− knockout mice will give rise to more information regarding its in vivo stability, functional specificity and potential toxicity.